Technical Analysis for IGMS - IGM Biosciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Flat | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 50 DMA | Bullish | -1.26% | |
| Pocket Pivot | Bullish Swing Setup | -1.26% | |
| Multiple of Ten Bearish | Other | -1.26% | |
| Wide Bands | Range Expansion | -1.26% | |
| Gapped Up | Strength | -1.26% | |
| 50 DMA Resistance | Bearish | 1.85% | |
| Inside Day | Range Contraction | 1.85% | |
| Wide Bands | Range Expansion | 1.85% | |
| Down 3 Days in a Row | Weakness | 1.85% | |
| 50 DMA Resistance | Bearish | 1.08% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | 13 minutes ago |
| Down 2 % | 13 minutes ago |
| 50 DMA Support | 34 minutes ago |
| 10 DMA Resistance | about 1 hour ago |
| Fell Below 50 DMA | about 1 hour ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/10/2024
Headquartered in Mountain View, California, IGM Biosciences is a biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immunology Antibodies Treatment Of Cancer Glycoproteins Biochemistry Protein Engineering Immunoglobulin M
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immunology Antibodies Treatment Of Cancer Glycoproteins Biochemistry Protein Engineering Immunoglobulin M
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 17.7 |
| 52 Week Low | 3.81 |
| Average Volume | 269,167 |
| 200-Day Moving Average | 8.50 |
| 50-Day Moving Average | 9.39 |
| 20-Day Moving Average | 8.96 |
| 10-Day Moving Average | 9.62 |
| Average True Range | 0.93 |
| RSI (14) | 51.69 |
| ADX | 13.99 |
| +DI | 27.15 |
| -DI | 19.72 |
| Chandelier Exit (Long, 3 ATRs) | 7.86 |
| Chandelier Exit (Short, 3 ATRs) | 9.17 |
| Upper Bollinger Bands | 11.04 |
| Lower Bollinger Band | 6.87 |
| Percent B (%b) | 0.63 |
| BandWidth | 46.59 |
| MACD Line | 0.09 |
| MACD Signal Line | 0.02 |
| MACD Histogram | 0.0641 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 10.70 | ||||
| Resistance 3 (R3) | 10.75 | 10.39 | 10.50 | ||
| Resistance 2 (R2) | 10.39 | 10.08 | 10.36 | 10.43 | |
| Resistance 1 (R1) | 9.94 | 9.89 | 9.76 | 9.89 | 10.36 |
| Pivot Point | 9.58 | 9.58 | 9.49 | 9.56 | 9.58 |
| Support 1 (S1) | 9.13 | 9.27 | 8.95 | 9.09 | 8.62 |
| Support 2 (S2) | 8.77 | 9.08 | 8.75 | 8.55 | |
| Support 3 (S3) | 8.33 | 8.77 | 8.48 | ||
| Support 4 (S4) | 8.28 |
